BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31101028)

  • 21. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
    Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
    AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer outcomes based on method of detection in community-based breast cancer registry.
    Bennett DL; Winter AM; Billadello L; Lowdermilk MC; Doherty CM; Kazmi S; Laster S; Al-Hammadi N; Hardy A; Kopans DB; Moy L
    Breast Cancer Res Treat; 2024 Jan; 203(2):215-224. PubMed ID: 37878149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Attendance in the second phase (2004-2005) of the Hungarian organized breast cancer screening program].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Budai A; Kövi R; Ember I
    Orv Hetil; 2008 Aug; 149(32):1491-8. PubMed ID: 18672438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of breast cancer screening measures among immigrant and Swiss women in Switzerland.
    Fontana M; Bischoff A
    Swiss Med Wkly; 2008 Dec; 138(49-50):752-8. PubMed ID: 19130329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proportion of women with self-reported opportunistic mammography before organized screening.
    Heikkinen S; Miettinen J; Koskenvuo M; Huovinen R; Pitkäniemi J; Sarkeala T; Malila N
    Acta Oncol; 2016 Jul; 55(7):865-9. PubMed ID: 27144814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening mammographies in Switzerland: what makes female and male physicians prescribe them?
    Keller B; Stutz EZ; Tibblin M; Ackermann-Liebrich U; Faisst K; Probst-Hensch N
    Swiss Med Wkly; 2001 Jun; 131(21-22):311-9. PubMed ID: 11584693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of breast cancer opportunistic screening on aesthetic surgical outcome: A single-center retrospective study in Switzerland.
    Marcon M; Dedes K; Varga Z; Frauenfelder T; Boss A
    Breast J; 2018 May; 24(3):285-290. PubMed ID: 28833850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attendance of the fourth (2008-2009) screening round of the Hungarian organized, nationwide breast cancer screening program].
    Boncz I; Döbrőssy L; Péntek Z; Kovács A; Budai A; Imre L; Vajda R; Sebestyén A
    Orv Hetil; 2013 Dec; 154(50):1975-83. PubMed ID: 24317356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
    Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
    Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast cancer screening in thirteen French departments].
    Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Dialla PO; Pornet C; Poillot ML; Soler-Michel P; Sarlin N; Lunaud P; Desmidt P; Paré E; Mathis C; Rymzhanova R; Kuntz-Huon J; Exbrayat C; Bataillard A; Régnier V; Kalecinski J; Quantin C; Dumas A; Gentil J; Amiel P; Chauvin F; Dancourt V; Arveux P
    Bull Cancer; 2015 Feb; 102(2):126-38. PubMed ID: 25636359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
    Kuklinski D; Blum M; Subelack J; Geissler A; Eichenberger A; Morant R
    Breast Cancer Res; 2024 May; 26(1):84. PubMed ID: 38802897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?
    Frede TE
    Eur J Radiol; 2005 Jul; 55(1):130-8. PubMed ID: 15925467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014.
    Karavasiloglou N; Matthes KL; Berlin C; Limam M; Wanner M; Korol D; Rohrmann S
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):653-660. PubMed ID: 30547321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening.
    Oberaigner W; Buchberger W; Frede T; Knapp R; Marth C; Siebert U
    BMC Public Health; 2010 Feb; 10():86. PubMed ID: 20170536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of the Czech National Breast Cancer screening programme].
    Skovajsová M; Májek O; Daneš J; Bartoňková H; Ngo O; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():69-78. PubMed ID: 25494891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].
    Molinié F; Billon-Delacour S; Allioux C; Blais S; Bercelli P; Lombrail P
    Rev Epidemiol Sante Publique; 2008 Feb; 56(1):41-9. PubMed ID: 18295424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results from the Swiss mammography screening pilot programme.
    Bulliard JL; De Landtsheer JP; Levi F
    Eur J Cancer; 2003 Aug; 39(12):1761-9. PubMed ID: 12888372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.